Circulating Free Methylated Tumor DNA Markers for Sensitive Assessment of Tumor Burden and Early Response Monitoring in Patients Receiving Systemic Chemotherapy for Colorectal Cancer Liver Metastasis
Conclusion:
Our data suggest that serial measurements of CRC-associated methylation markers could be a particularly valuable tool for early response assessment in patients receiving neoCTx for CLM.
Source: Annals of Surgery - Category: Surgery Tags: ESA Papers Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | Colorectal Cancer | Genetics | Liver | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Study | Urology & Nephrology